JAGX extends royalty payments and note maturity by 3 months to Jan 2027

JAGX extended the maturity date of two $12 million royalty interests (Uptown and Streeterville) and a $6.2 million secured note from October 1, 2026 to January 1, 2027, indicating near-term cash constraints requiring negotiated delays. The company also granted consent to preferred stock modifications in exchange for additional contingent repurchase obligations upon a Fundamental Transaction, which signals refinancing stress and weakened negotiating position.

Jaguar Health pushed back three debt payments by three months to January 2027 and gave a preferred investor extra rights in case of a major deal, suggesting cash flow pressure.